lidoflazine

This page covers all lidoflazine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Equilibrative nucleoside transporter 1, Potassium voltage-gated channel subfamily H member 2, Sodium channel alpha subunits; brain (Types I, II, III).

Targets

Equilibrative nucleoside transporter 1, Potassium voltage-gated channel subfamily H member 2, Sodium channel alpha subunits; brain (Types I, II, III)

Phase 2 pipeline (1)

• Corflazine · Other
  Corflazine works by blocking potassium channels in the body, which helps to regulate the electrical activity of cells.

Patent intelligence

• lidoflazine patent landscape — aggregated cliff calendar, attackable patents, originator estates